skip to Main Content

Free Newsletter: Actionable insight every morning for the self-directed investor. Find out more

Despite spending the bulk of the session in positive territory, London’s AIM Index slipped back in line with the US open, reaching the bell just over one and a half points lower at 1252.70

  • St James House +40%
  • I-Nexus Global +38%
  • Yourgene Health +10%
  • Pantheon Resources -43%
  • Agriterra -18%

St James House [LON:SJH] was the day’s biggest riser, coming close to adding 100% at one point off the back a well received statement ahead of the company’s AGM. That was pertaining to a partnership which has effected a change management process starting tomorrow. Some of the upside ebbed away however, but the stock still closed up 40% on the day.


I-Nexus Global [LON:INX] also fared well, adding 38% by the bell and extending the rally which kicked off before the weekend break. Perhaps tellingly, there was no notification from the company this morning regarding the abnormal share price movement, heightening suspicion that contract news may be afoot. Long term investors who have seen the stock languish for the last year will be rightly pleased.

Pantheon Resources [LON:PANR] was by the bell the day’s biggest casualty, sitting some 43% adrift. An operational update released this morning, whilst containing some encouraging news, concluded with the CEO admitting disappointment that they hadn’t yet managed to deliver the proof of high flow rates they had been hoping for. The news has reversed more than six months of share price growth for the company and further testing progress will apparently have to wait until next winter.

Minnow Agriterra [LON:AGTA] made for the day’s second biggest faller, finishing some 18% lower although with a sub £1m market cap, a hulking spread of almost 50% being quoted and very limited trade, being seen, it appears here as a technical note and not much else.

A notable mention to Yourgene Health [LON:YGEN], which we flagged in our morning report following news it had made it to the tender round of a government COVID programme, bidding for a slice of £3bn worth of work. A mid-session update added to the good news, with word that the company had also made it into another bidding lot which could prove even more lucrative, although as was stressed in the earlier statement, there are no guarantees of contracts being won. Shares reached the bell some 10% higher.

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.

Comments


Back To Top